Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallvard Holdaas

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2008
Long-term clinical outcome of paediatric kidneys transplanted to adultsAksel Foss, Anne Gunther, Pål-Dag Line, et al.
Arthritis and Rheumatism|April 1, 2009
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled studyGudrun E Norby, Ingar Holme, Bengt Fellström, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
Kidney International|October 23, 2009
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipientsSadollah Abedini, Andreas Meinitzer, Ingar Holme, et al.
Arthritis and Rheumatism|March 2, 2011
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantationGudrun E Norby, Torbjørn Leivestad, Geir Mjøen, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Transplantation|November 30, 2012
The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trialsInga Soveri, Jon Snyder, Hallvard Holdaas, et al.
Transplantation|August 12, 2009
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantationTone G Valderhaug, Trond Jenssen, Anders Hartmann, et al.
Journal of Lipid Research|June 15, 2007
Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientsJonathan B Singer, Hallvard Holdaas, Alan G Jardine, et al.
Current Medical Research and Opinion|February 13, 2009
Cardiovascular disease in patients with renal disease: the role of statinsBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2008
Long-term clinical outcome of paediatric kidneys transplanted to adultsAksel Foss, Anne Gunther, Pål-Dag Line, et al.
Arthritis and Rheumatism|April 1, 2009
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled studyGudrun E Norby, Ingar Holme, Bengt Fellström, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
Kidney International|October 23, 2009
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipientsSadollah Abedini, Andreas Meinitzer, Ingar Holme, et al.
Arthritis and Rheumatism|March 2, 2011
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantationGudrun E Norby, Torbjørn Leivestad, Geir Mjøen, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Transplantation|November 30, 2012
The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trialsInga Soveri, Jon Snyder, Hallvard Holdaas, et al.
Transplantation|August 12, 2009
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantationTone G Valderhaug, Trond Jenssen, Anders Hartmann, et al.
Journal of Lipid Research|June 15, 2007
Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientsJonathan B Singer, Hallvard Holdaas, Alan G Jardine, et al.
Current Medical Research and Opinion|February 13, 2009
Cardiovascular disease in patients with renal disease: the role of statinsBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.
Pageof 16